Blockchain Registration Transaction Record
Quantum BioPharma Advances in Brain Disorders and Alcohol Health Solutions
Quantum BioPharma (QNTM) progresses in treating brain disorders and alcohol health, with new clinical trials and strategic updates. Discover their innovative solutions.

Quantum BioPharma's developments are crucial for patients suffering from neurodegenerative and metabolic disorders, as well as alcohol misuse. Their innovative treatments, like Lucid-MS for Multiple Sclerosis and FSD202 for inflammatory pain, offer hope for conditions with limited therapeutic options. The company's strategic moves, including potential IPOs and Bitcoin investments, also signal growth and stability, making it a noteworthy player in the biopharmaceutical sector.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0xd9b91df856846e2c2ae1e4fcd26555417790250cd976c908b5910a42699dd55a |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | knotRPlf-006b7e89e6de1478e6a5489ff9a731e3 |